A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States
GLUCAGON-LIKE peptide-1 (GLP-1) receptor agonists use in patients with Type 2 diabetes is modestly associated with an increased rate of erectile dysfunction, a 2026 target trial emulation has found
Across the trials, the drugs were linked to reductions in binge eating severity, less disinhibited eating (where people struggle to resist food despite not being physically hungry), and fewer episodes of feeling out of control while eating
industrial policy, as the U.S
But alongside these benefits, some also notice unexpected changes in their menstrual cycle - such as new cramping, spotting, or shifts in flow
Many cases of MTC are also linked to a genetic condition called Multiple Endocrine Neoplasia type 2 (MEN2)